TransformativeMed
Latest round
- Series A
Last raised
- May 2019
Total raised
- $5.8M
Investors
- 1
About TransformativeMed
TransformativeMed, Inc.TransformativeMed, Inc. specializes in advanced clinical solutions aimed at glycemic management. Erik Van Eaton is the founder, while David Stone and Doug Cusick currently serve as CEOs.TransformativeMed specializes in providing cutting-edge clinical solutions with a focus on glycemic management through its flagship offering, the CORES Platform. This platform is designed by clinicians for clinicians and integrates seamlessly into Electronic Health Records (EHR) systems to enhance workflow efficiency and patient care quality. Key features of the CORES Platform include specialty-specific provider worklists, automated protocols for insulin dosing, real-time notifications, and comprehensive decision-support tools that streamline pre-rounding, rounding, and discharge planning processes. The company primarily serves hospitals and healthcare providers, enhancing the daily operations of clinical teams across various specialties, particularly in diabetes management.TransformativeMed generates revenue through a subscription-based model, wherein healthcare institutions pay for access to the CORES Platform and its suite of clinical solutions. Clients, which include hospitals and medical practices, often enter long-term partnerships that facilitate continuous integration and support of the platform within their existing EHR systems. The revenue structure typically involves tiered pricing plans based on the size of the institution and the specific modules utilized, allowing for customizable solutions that meet the diverse needs of various healthcare providers. The company aims to expand into additional markets across Europe by 2023, focusing on regions where diabetes management solutions are critically needed. This expansion will involve adapting the CORES Platform to meet specific regional healthcare needs, further solidifying TransformativeMed's position in the healthcare technology landscape.
Who invested in TransformativeMed
1 investor across 1 round
See all investors in TransformativeMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 7, 2019
Amount
$5.8M
Investors
Questions about TransformativeMed
Who invested in TransformativeMed?
TransformativeMed has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TransformativeMed raised?
TransformativeMed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TransformativeMed last raise money?
TransformativeMed's most recent round on record is a Series A, in May 2019.
What does TransformativeMed do?
TransformativeMed is a software company.
Where is TransformativeMed headquartered?
TransformativeMed is headquartered in Seattle, US.
Which VCs invest in companies like TransformativeMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at TransformativeMed's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like TransformativeMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.